Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/28/25 16:52 | 4/3/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | 17 | S.dm | -9,059 | 8.02 | 0 | -1,129 | 1,273 | M | |||||||||||||||
11/14/24 19:19 | 11/12/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Borgeson Blake | UT | D | 24 | S | -3,106 | 9.27 | 0 | -335 | 7,364 | D | ||||||||||||||||
11/14/24 19:19 | 11/12/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 10 | S.dm | -3,224 | 8.53 | 0 | -378 | 1,500 | D | |||||||||||||||
10/28/24 17:25 | 2/22/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Marriott Tina | UT | O | P,COO | 11 | S.d | -639 | 9.40 | 0 | -68 | 640 | D | |||||||||||||||
1/18/24 18:39 | 1/16/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Virani Shafique | UT | O | Chief Bu | 1 | S.d | -197 | 10.93 | 0 | -18 | 137 | D | |||||||||||||||
1/11/24 18:51 | 1/9/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Li Dean Y | UT | D | 1 | S | -396 | 13.66 | 0 | -29 | 3,171 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |